RNA (Avidity Biosciences Inc) Bathi saben saham sajroning taun lumaku
The annual EPS growth rate over the last 12 months demonstrates how market quotes react to the elite status of the RNA therapy developers, where patents protect the business from tech giants. Avidity Biosciences (RNA) saw this metric reach 0.00, confirming the success of its unique drug delivery system to muscles. Meanwhile, Avidity Biosciences (RNA) strictly adheres to bio-waste disposal standards, minimizing its environmental impact.
%20Avidity%20Corp&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_RNA_-_Avidity-Biosciences_-_Net-earnings-per-share-EPS-TTM "RNA (Avidity Corp) riwayat Bathi saben saham sajrone rolas wulan pungkasan saka 11.02.2024 nganti 14.11.2026 | 👁️GURU.Markets👁️")
RNA (Avidity): rincian analitis lan laporan miturut indikator
- rega lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
- statistik nilai buku emiten:
- indikator total utang lan likuiditas perusahaan:
Utang marang Modal Avidity Biosciences|RNA - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Avidity Corp|RNA - Gunggung utang perusahaan|Utang marang nilai buku Avidity Biosciences Inc|RNA - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Avidity Biosciences|Likuiditas darurat aviditybiosciences.com
- indikator bathi lan kelipatan valuasi:
RNA - Bathi resik perusahaan|Prakiraan bathi resik Avidity Biosciences|RNA - Pangali P/E|Prakiraan rega marang bathi Avidity Biosciences Inc|RNA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Avidity Biosciences Inc|RNA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Avidity Biosciences|RNA - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan aviditybiosciences.com|RNA - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Avidity Biosciences
- indikator dodolan lan pendapatan:
Pambiji fundamental perusahaan:Avidity Biosciences
Investors are assessing the resilience of Avidity Biosciences (RNA) through net earnings per share dynamics, which measure the annual growth rate of equity value by smoothing out quarterly fluctuations. By analyzing the history of EPS YoY (TTM) percentage changes, one can correlate financial performance with advancements in AOC therapy development and R&D cost control, allowing for a determination of the business's actual expansion stage.
Analisis pesaing Avidity Biosciences
Bathi resik saben siji saham sajrone rolas wulan pungkasan Tempus AI, Inc.|QGEN (Qiagen) - Bathi resik saben saham sajrone 12 wulan pungkasan|Ionis Pharmaceuticals, Inc. - Bathi saben saham sajroning taun lumaku|RGEN (Repligen Corp.) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan CRSP|Bathi resik saben saham (EPS TTM) WGS|Bathi resik saben saham sajrone patang kuartal pungkasan ultragenyx.com|Bathi saben saham sajrone rolas wulan pungkasan Beam Therapeutics BEAM|Sarepta Therapeutics (SRPT) - Bathi resik saben siji saham sajrone rolas wulan pungkasan|TWST - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben saham sajrone patang kuartal pungkasan 10x TXG|NTLA: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan stoketherapeutics.com|BLFS (BioLife Solutions) - Bathi resik saben saham (EPS TTM)|Wave Life Sciences Ltd (WVE) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi resik saben saham (EPS TTM) MAZE|SION - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Prime Medicine, Inc. PRME|TSHA: Bathi saben saham sajrone 12 wulan pungkasan|uniQure - Bathi resik saben saham (EPS TTM)|MeiraGTx Holdings (MGTX) - Bathi resik saben saham sajrone 12 wulan pungkasan|RGNX: Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan Solid Corp (SLDB)|Bathi saben saham sajrone rolas wulan pungkasan Ocugen, Inc.|pacb.com (PACB) - Bathi resik saben saham sajrone patang kuartal pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Benitec Biopharma (BNTC)|DSGN (Design Therapeutics Inc) - Bathi saben saham sajroning taun lumaku|Bathi saben saham sajrone rolas wulan pungkasan Rocket Pharmaceuticals Inc RCKT|FDMT: Bathi saben saham sajrone 12 wulan pungkasan|Lexeo - Bathi resik saben saham (EPS TTM)|KRRO - Bathi resik saben saham (EPS TTM)|EDIT: Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone 12 wulan pungkasan SLN|Bathi saben saham sajrone rolas wulan pungkasan ProQR|Bathi saben saham sajrone 12 wulan pungkasan CDXS (Codexis Bio)|Bathi resik saben saham (EPS TTM) SGMO|Bathi resik saben saham (EPS TTM) nautilus.bio (NAUT)|Bathi resik saben saham (EPS TTM) MGX (Metagenomi)|Bathi resik saben saham (EPS TTM) Precision BioSciences Inc. DTIL|GBIO: Bathi resik saben saham sajrone 12 wulan pungkasan|BOLD: Bathi saben saham sajrone rolas wulan pungkasan|XCUR: Bathi resik saben saham (EPS TTM)|IMNN - Bathi resik saben saham sajrone patang kuartal pungkasan|PHIO (Phio Pharmaceuticals Corp) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone 12 wulan pungkasan MBIO (Mustang Bio Corp)|Bathi resik saben saham (EPS TTM) RNAZ|Bathi resik saben saham sajrone patang kuartal pungkasan bionanogenomics.com|Applied DNA Sciences - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan BLUE (bluebirdbio.com)|IPA: Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan Omega Therapeutics Inc|OMIC (Singular Genomics Systems Inc) - Bathi resik saben saham sajrone 12 wulan pungkasan|Regulus - Bathi saben saham sajroning taun lumaku|SYRS (Syros Pharmaceuticals) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan TBIO|Bathi resik saben saham (EPS TTM) TCON|Bathi resik saben saham sajrone patang kuartal pungkasan Unity Biotechnology Inc.
